On the fly News and insights, exclusive to thefly.com

MDGL

Madrigal Pharmaceuticals

$289.68

2.42 (0.84%)

, TSRO

Tesaro

$40.25

-0.71 (-1.73%)

06:28
07/20/18
07/20
06:28
07/20/18
06:28

After Tesaro report, Intereconomia says Merck KGaA to acquire Madrigal

Shares of Madrigal Pharmaceuticals (MGDL) are slightly higher after Spanish media group Intereconomia reported that Germany's Merck KGaA (MKGAY) will likely acquire the company next week. Intereconomia in June reported that Roche (RHHBY) could announce a buyout of Tesaro (TSRO) in the coming days. A deal for Tesaro is yet to be announced. Merck has presented its best offer for Madrigal and beat out two competitors for the acquisition, Intereconomia reports, citing sources familiar with the process. The purchase will be made next week, the website says. Shares of Madrigal are up $1.28 to $290.00 in premarket trading. Reference Link

MDGL

Madrigal Pharmaceuticals

$289.68

2.42 (0.84%)

TSRO

Tesaro

$40.25

-0.71 (-1.73%)

MKGAY

Merck KGaA

$0.00

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

  • 08

    Aug

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.